An Investigational Drug for HER2-, CLDN18.2+ Locally advanced Unresectable or Metastatic Gastric/GEJ Cancer Event Type: Webinars Date: Thursday, Aug. 24, 2023 at 2–3 pm ET Member: Free Non-Member: Free Register Link
